ArticleJournal of cardiology cases2013
Sick sinus syndrome induced by interferon and ribavirin therapy in a patient with chronic hepatitis C.
Article in Journal of cardiology cases, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
23 citing papers in PubMed, 1 synthesis or guideline pooled it, 45 citations in OpenAlex.
- Children's heart and COVID-19: Up-to-date evidence in the form of a systematic review.European journal of pediatrics · 2020Pooled it
- Article
- Cardiovascular adverse effects of immunotherapy in cancer: insights and implications.Frontiers in oncology · 2025Review
- Mortality Prediction of COVID-19 in Hospitalized Patients Using the 2020 Diagnosis Procedure Combination Administrative Database of Japan.Internal medicine (Tokyo, Japan) · 2023Article
- Bibliometric and visual analysis of cardiovascular diseases and COVID-19 research.Frontiers in public health · 2022Article
- Host factors facilitating SARS-CoV-2 virus infection and replication in the lungs.Cellular and molecular life sciences : CMLS · 2021Review
- Cardiovascular impact of COVID-19: an array of presentations.Acta bio-medica : Atenei Parmensis · 2021Article
- Antimalarial and cytotoxic drugs on COVID-19 and the cardiovascular burden: Literature review and lessons to be learned.Vascular · 2021Review
- A meta-meta-analysis: Evaluation of meta-analyses published in the effectiveness of cardiovascular comorbidities on the severity of COVID-19.Obesity medicine · 2021Review
- Cardiac Injury Biomarkers and the Risk of Death in Patients with COVID-19: A Systematic Review and Meta-Analysis.Cardiology research and practice · 2021Review
- SARS-CoV-2 Infection and Cardioncology: From Cardiometabolic Risk Factors to Outcomes in Cancer Patients.Cancers · 2020Review
- Endothelial glycocalyx damage as a systemic inflammatory microvascular endotheliopathy in COVID-19.Biomedical journal · 2020Review
- How to overcome cardiovascular challenges in COVID-19 patients: a guide for common practice.Acta bio-medica : Atenei Parmensis · 2020Review
- Association between COVID-19 and cardiovascular disease.International journal of cardiology. Heart & vasculature · 2020Review
- Coronavirus disease 2019 and cardiovascular system: A narrative review.International journal of cardiology. Heart & vasculature · 2020Review
- Current Perspectives on Coronavirus Disease 2019 and Cardiovascular Disease: A White Paper by theJournal of the American Heart Association · 2020Review
- Cardiac involvement in COVID-19 patients: Risk factors, predictors, and complications: A review.Journal of cardiac surgery · 2020Review
- COVID-19, State of the Adult and Pediatric Heart: From Myocardial Injury to Cardiac Effect of Potential Therapeutic Intervention.Frontiers in cardiovascular medicine · 2020Review
- Single Virus Targeting Multiple Organs: What We Know and Where We Are Heading?Frontiers in medicine · 2020Review
- Geriatric challenges in the new coronavirus disease-19 (COVID-19) pandemic: A systematic review.Medical journal of the Islamic Republic of Iran · 2020Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The therapeutic effect of interferon (IFN) on chronic hepatitis C and its adverse effects have been well documented. Although the incidence of IFN-related cardiotoxicity is low, careful observation is necessary because of its possible fatal outcome. We describe a 45-year-old woman who suffered from sinus node dysfunction after the combination therapy of pegylated IFN-alpha and ribavirin for chronic hepatitis C. Despite the cessation of IFN therapy, sinus node dysfunction was not reversible, and led her to the implantation of permanent pacemaker. Physicians should therefore be aware of the possibility of sinus node dysfunction in patients receiving IFN therapy. <
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.